Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions

According to Spratt, clinicians have long lacked a reliable tool to support decision-making in this setting—a gap the ArteraAI Prostate Test was developed to address.

Spratt explained, “This [test] uses [patients’] clinical and pathologic…